Literature DB >> 14517213

Insulin-like growth factor-II regulates PTEN expression in the mammary gland.

Roger A Moorehead1, Carlo V Hojilla, Ian De Belle, Geoffrey A Wood, Jimmie E Fata, Eileen D Adamson, Katrina L M Watson, Dylan R Edwards, Rama Khokha.   

Abstract

The tumor suppressor PTEN is altered in many cancers, including breast cancer, but only a handful of factors are known to control its expression. PTEN plays a vital role in cell survival and proliferation by regulating Akt phosphorylation, a key component of the phosphatidylinositol 3 kinase (PI3K) pathway. Here we show that insulin-like growth factor-II (IGF-II), which signals through PI3K, regulates PTEN expression in the mammary gland. IGF-II injection into mouse mammary gland significantly increased PTEN expression. Transgenic IGF-II expression also increased mammary PTEN protein, leading to reductions in Akt phosphorylation, epithelial proliferation, and mammary morphogenesis. IGF-II induced PTEN promoter activity and protein levels and this involved the immediate early gene egr-1. Thus, we have identified a novel negative feedback loop within the PI3K pathway where IGF-II induces PTEN expression to modulate its physiologic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517213     DOI: 10.1074/jbc.M306894200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.

Authors:  Dongdong Lu; Chang Han; Tong Wu
Journal:  Gastroenterology       Date:  2011-02-24       Impact factor: 22.682

2.  Involvement of IGF-2, IGF-1R, IGF-2R and PTEN in development of human tooth germ - an immunohistochemical study.

Authors:  Darko Kero; Livia Cigic; Ivana Medvedec Mikic; Tea Galic; Mladen Cubela; Katarina Vukojevic; Mirna Saraga-Babic
Journal:  Organogenesis       Date:  2016-06-21       Impact factor: 2.500

Review 3.  Friend or foe, the role of EGR-1 in cancer.

Authors:  Tong-Tong Li; Man-Ru Liu; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2019-11-20       Impact factor: 3.064

Review 4.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

5.  Differential expression and signaling activation of insulin receptor isoforms A and B: A link between breast cancer and diabetes.

Authors:  S Kalla Singh; C Brito; Q W Tan; M De León; D De León
Journal:  Growth Factors       Date:  2011-09-13       Impact factor: 2.511

Review 6.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

Review 7.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

Review 8.  PTEN function: how normal cells control it and tumour cells lose it.

Authors:  Nick R Leslie; C Peter Downes
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

Review 9.  IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

Authors:  Claire M Perks; Jeff M P Holly
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-25       Impact factor: 2.673

10.  A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development.

Authors:  Sarah M Francis; Jacqueline Bergsied; Christian E Isaac; Courtney H Coschi; Alison L Martens; Carlo V Hojilla; Subrata Chakrabarti; Gabriel E Dimattia; Rama Khoka; Jean Y J Wang; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2009-06-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.